SI

SillaJen, Inc.

Develops oncolytic viruses and immunotherapeutics to destroy difficult-to-treat cancer cells.

215600 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 중구 청계천로 106 3층(수표동, 크리스탈스퀘어), 중구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

SillaJen, Inc. is a biotechnology company focused on the research, development, and commercialization of oncolytic immunotherapeutics for cancer treatment. The company engineers oncolytic viruses designed to selectively replicate in and destroy cancer cells while stimulating a systemic anti-tumor immune response. Its main pipeline candidate is Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus that has been investigated for the treatment of various solid tumors. SillaJen is dedicated to developing innovative therapeutic options for patients with difficult-to-treat cancers through its proprietary viral engineering platforms.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for SillaJen, Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-09 00:00
Legal Proceedings Report
투자판단관련주요경영사항(임상시험계획변경승인) (진행성 고형암 또는 재발성/불응성 급성 골수성 백혈병 환자를 대상으로 B…
Korean 28.0 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.9 MB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-08-05 00:00
Regulatory News Service
불성실공시법인지정 (공시변경)
Korean 6.1 KB
2025-07-15 00:00
Legal Proceedings Report
투자판단관련주요경영사항(임상시험계획변경승인신청) (진행성 고형암 또는 재발성/불응성 급성 골수성 백혈병 환자를 대상으로…
Korean 26.9 KB
2025-07-11 00:00
Regulatory News Service
불성실공시법인지정예고 (공시변경)
Korean 5.0 KB

Automate Your Workflow. Get a real-time feed of all SillaJen, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SillaJen, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Respiratorius AB Logo
Develops oncology pre-treatment drugs to enhance the efficacy of standard cancer therapies.
Sweden RESP
REYON PHARMACEUTICAL CO., LTD Logo
Develops & makes APIs, generics, cell/gene therapies, and offers biopharma CDMO services.
South Korea 102460
Roche Holding AG Logo
A global leader in pharmaceuticals and diagnostics, pioneering personalized healthcare solutions.
Switzerland RO
ROHTO PHARMACEUTICAL CO.,LTD. Logo
Manufactures OTC drugs, skincare, and cosmetics with a focus on eye and dermatological health.
Japan 4527
RPbio Inc. Logo
A global CDMO specializing in soft capsules, pharmaceuticals, and health functional foods.
South Korea 314140
Develops and produces IVD kits and biological pharmaceuticals for the healthcare sector.
Türkiye RTALB
SAMIL PHARMACEUTICAL CO.,LTD Logo
Develops & manufactures drugs for eye & liver diseases, with a broad portfolio & CDMO services.
South Korea 000520
SAMJIN PHARMACEUTICAL CO.,LTD Logo
Researches & develops drugs for cardiovascular, respiratory, and gastrointestinal disorders.
South Korea 005500
SAMSUNG BIOLOGICS CO.,LTD. Logo
A CDMO providing end-to-end development and manufacturing services for the biopharma industry.
South Korea 207940
SanBio Company Limited Logo
Developing regenerative cell therapies for severe neurological disorders like brain injury and stroke.
Japan 4592

Talk to a Data Expert

Have a question? We'll get back to you promptly.